Harris Todd — SEC Form 4 filings
SEC reporting owner CIK 1711463. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-06 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 6 filings — 250,000 shares, $5,570,268 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 78,996 shares @ $16.45 ($1,299,160) in Tyra Biosciences, Inc., filed 2024-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | President and CEO, Director | 14 | — | 20 legs · 250,000 sh · $5,570,268 | 9 |
Form 4 filings — Harris Todd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 864 @ $9.13 | EDGAR |
| 2026-05-07 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 79,000 @ $0 · Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,463 @ $9.13 | EDGAR |
| 2025-08-07 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 570,000 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,241 @ $9.78 | EDGAR |
| 2024-10-22 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 43,636 @ $27.01 · Sale (S): 5,896 @ $27.32 · Sale (S): 13,188 @ $28.16 | EDGAR |
| 2024-10-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 10,035 @ $24.31 · Sale (S): 4,900 @ $25.22 · Sale (S): 24,475 @ $26.23 · Sale (S): 3,922 @ $26.98 · Sale (S): 15,194 @ $25.84 · Sale (S): 200 @ $26.37 | EDGAR |
| 2024-10-02 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 500 @ $24 | EDGAR |
| 2024-09-25 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 10,092 @ $24.13 · Sale (S): 1,055 @ $24.02 · Sale (S): 600 @ $24.01 | EDGAR |
| 2024-09-20 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 3,500 @ $24 · Sale (S): 5,671 @ $24.30 · Sale (S): 27 @ $25.10 · Sale (S): 7,109 @ $24.19 | EDGAR |
| 2024-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,350 @ $6.58 | EDGAR |
| 2024-08-16 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 390,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Tyra Biosciences, Inc. (TYRA) | Grant/award (A): 1,880 @ $6.58 | EDGAR |
| 2024-02-06 | 4 | Tyra Biosciences, Inc. (TYRA) | Sale (S): 78,996 @ $16.45 · Sale (S): 7,187 @ $17.04 · Sale (S): 13,817 @ $16.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711463 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →